A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
- Matthew Mahoney
- , Vishnu C. Damalanka
- , Michael A. Tartell
- , Dong hee Chung
- , Andre Luiz Lourenço
- , Dustin Pwee
- , Anne E. Mayer Bridwell
- , Markus Hoffmann
- , Jorine Voss
- , Partha Karmakar
- , Nurit P. Azouz
- , Andrea M. Klingler
- , Paul W. Rothlauf
- , Cassandra E. Thompson
- , Melody Lee
- , Lidija Klampfer
- , Christina L. Stallings
- , Marc E. Rothenberg
- , Stefan Pohlmann
- , Sean P.J. Whelan
- Department of Biochemistry & Molecular Biophysics
- Department of Molecular Microbiology
- Bursky Center for Human Immunology and Immunotherapy
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- School of Medicine
- COVID-19 Researchers
- Siteman Cancer Center
- DBBS - Plant and Microbial Biosciences
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Molecular Cell Biology
- DBBS - Cancer Biology
- Center for Women's Infectious Disease Research (cWIDR)
- Center of Regenerative Medicine
Research output: Contribution to journal › Article › peer-review
106
Link opens in a new tab
Scopus
citations